Crohn Disease (CD)TRANSIT CDNCT07794410
A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect and Classify Perianal Fistulas in Patients With Crohn's Disease or Fistulas of Unknown Cause
A study testing Transperineal Ultrasound (TPUS), Magnetic Resonance Imaging (MRI) and Endoscopic Ultrasound (EUS) in people with Crohn Disease (CD) and Cryptoglandular Perianal Fistula, run by Asian Institute of Gastroenterology, India at 1 site in India.
Trial summary
The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with Crohn's disease or fistulas with no known cause (cryptogenic). Perianal fistulas are painful tunnels that form near the anus and can lead to discharge, swelling, or infection. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Crohn Disease (CD), Cryptoglandular Perianal Fistula
- What is being tested?
- Transperineal Ultrasound (TPUS), Magnetic Resonance Imaging (MRI) and Endoscopic Ultrasound (EUS)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteIndia
- Study dates
- 25 Jul 2025to 30 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults between 18 and 75 years of age
- Clinical suspicion or diagnosis of perianal fistula
- Fistula etiology can be Crohn's disease or cryptogenic/tubercular (non-Crohn's)
- Ability to undergo all four imaging procedures (TPUS, MRI, EUS, and EUA) within a 10-day period
- Willing and able to provide written informed consent
Who cannot join
- Known or suspected anorectal malignancy
- Pregnancy or breastfeeding
- Contraindications to any of the imaging procedures:
- MRI (e.g., presence of metal implants or claustrophobia)
- EUS (e.g., severe anal stenosis or intolerance to procedure)
- Anesthesia required for EUA (e.g., significant cardiopulmonary disease)
Show all 9Show fewer
- Prior surgery or seton placement at the index fistula site
- Incomplete or failed imaging in any one of the modalities
- Inability to provide informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
India1 site, 1 recruiting
- Recruiting
Asian Institute of Gastroenterology
Hyderabad, Telanagana, 500082
Partha Pal, MD, DNB, MRCP (UK), FASGE, +91-8945906823, partha0123456789@gmail.com
About this study
Official title: A Quadrimodal Comparison of Transperineal Ultrasound and Magnetic Resonance Imaging-based Sonographic Investigation With Integrated Testing Using Endoscopic Ultrasound and Examination Under Anesthesia for the Assessment of Perianal Fistulas in Patients With Crohn's Disease and Fistulas of Cryptogenic Origin (TRANSIT-CD Study)
The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with Crohn's disease or fistulas with no known cause (cryptogenic). Perianal fistulas are painful tunnels that form near the anus and can lead to discharge, swelling, or infection. The main questions this study aims to answer are:
How accurate is transperineal ultrasound (TPUS) compared to magnetic resonance imaging (MRI) in finding fistulas? How well do these tests identify key features like internal openings and abscesses? Do the test results help doctors make better treatment decisions?
Read more
Researchers will compare TPUS and MRI to two other imaging methods:
Endoscopic ultrasound (EUS), which uses a small camera and ultrasound inside the rectum Examination under anesthesia (EUA), in which a surgeon checks the area while the participant is asleep
All participants will:
Be adults between the ages of 18 and 75 Have a suspected or confirmed perianal fistula Be able to complete all four tests-TPUS, MRI, EUS, and EUA-within 10 days Participants will not receive any experimental treatments. The tests are part of routine care and will be done using advanced equipment by expert doctors. Each test result will be used to compare how accurate and useful the test is in real-life diagnosis and treatment planning.
This study may help make fistula diagnosis faster, safer, and more affordable-especially in settings where access to MRI or surgery is limited. It may also support the use of TPUS as a first step in evaluating perianal fistulas in people with Crohn's disease.
Read the detailed description
Perianal fistulas are a challenging and often debilitating complication of anorectal and inflammatory bowel diseases, particularly Crohn's disease. Up to 40% of people with Crohn's disease may develop perianal fistulas during the course of their illness. These fistulas are frequently complex, may recur, and can severely affect quality of life. They are associated with symptoms such as discharge, swelling, pain, infection, and, in some cases, incontinence or systemic sepsis. Accurate diagnosis and anatomical characterization of these fistulas are essential for determining the most effective medical and surgical treatment strategies.
Traditional imaging strategies include Magnetic Resonance Imaging (MRI), which is currently considered the non-invasive standard for anatomical delineation, and Examination Under Anesthesia (EUA), which serves as the gold standard due to the ability to directly examine the anatomy and intervene surgically if necessary. However, both methods have limitations. MRI is costly, may not be readily available in resource-limited settings, and is not suitable for all patients (e.g., those with certain implants or claustrophobia). EUA is invasive, requires anesthesia, and may not be feasible for repeated use in follow-up or outpatient care.
Alternative imaging modalities such as Transperineal Ultrasound (TPUS) and Endoscopic Ultrasound (EUS) are being explored for their diagnostic utility. TPUS is a non-invasive, low-cost, real-time modality that can be performed at the bedside or in outpatient settings. EUS, while more invasive, offers high-resolution images of the anal canal and surrounding structures and is increasingly used for evaluating anorectal diseases.
The TRANSIT-CD study (A Quadrimodal Comparison of TRAnsperiNeal and MR-based Sonographic Investigation with Integrated Testing using Endoscopic Ultrasound and Examination Under Anesthesia) is a prospective, single-center, diagnostic accuracy study designed to compare the performance of four imaging modalities-TPUS, MRI, EUS, and EUA-in evaluating perianal fistulas in people with Crohn's disease and cryptogenic (non-Crohn's) fistulas.
Study Design and Objectives The study will enroll adults aged 18 to 75 years with a clinical diagnosis or suspicion of perianal fistula. Each participant will undergo four imaging tests-TPUS, MRI, EUS, and EUA-within a maximum interval of 10 days. The order of testing is predefined and all interpretations will be performed independently by blinded experts in each modality.
The primary objective is to compare the per-lesion sensitivity of TPUS and MRI for detecting perianal fistulas, using EUS as the reference standard and EUA as the gold standard.
Secondary objectives include:
Comparing TPUS and MRI for detecting internal openings and perianal abscesses Evaluating classification accuracy using Parks classification and American Gastroenterological Association (AGA) criteria (simple vs. complex fistulas) Determining whether findings from TPUS and MRI result in a change in clinical management
Exploratory objectives include:
Assessing diagnostic accuracy by disease type (Crohn's vs. cryptogenic) Comparing modality performance in high (above the levator ani muscle) vs. low fistulas Evaluating inter-modality agreement and confidence levels of reporting physicians Methodology
Transperineal Ultrasound (TPUS) Performed by an expert radiologist using a high-end ultrasound platform with microconvex and high-frequency linear probes. The patient is positioned in the left lateral decubitus position. Both axial and sagittal images are obtained. Parameters assessed include tract presence, type, internal openings, secondary extensions, and associated abscesses.
Magnetic Resonance Imaging (MRI) Conducted using a 1.5 Tesla MRI scanner with T2-weighted, STIR, and post-contrast T1-weighted fat-suppressed sequences in axial, sagittal, and coronal planes. MRI findings are independently interpreted by radiologists blinded to TPUS and EUS findings. Fistulas are characterized using standard classification systems and the presence of abscesses and internal openings is documented.
Endoscopic Ultrasound (EUS) EUS is performed using a linear echoendoscope and dedicated EUS processor. The procedure does not require bowel preparation. A 360-degree evaluation of the anal canal and surrounding structures is performed to detect fistulous tracts, internal openings, and collections. EUS serves as the reference standard for diagnostic comparison.
Examination Under Anesthesia (EUA) EUA is performed by an experienced colorectal surgeon under spinal or general anesthesia. This procedure allows direct probing of the fistula tract, identification of internal openings, and classification of the fistula using tactile and visual assessment. EUA is considered the gold standard in this study.
Each modality's findings are documented in structured case report forms. The findings include:
Fistula presence and number Parks classification and AGA complexity score Internal and external openings Abscess presence and dimensions Secondary tracts Confidence scores All data are recorded per lesion, per patient.
Blinding and Data Integrity All imaging studies will be interpreted independently by modality-specific experts, who are blinded to the findings of other modalities. Discrepant findings will be resolved through consensus by the principal investigators. A secure electronic database will be used for data capture, ensuring patient confidentiality and auditability.
Clinical Impact Assessment The study will also track whether imaging findings lead to a change in management plans (e.g., additional imaging, medical therapy, surgical planning). These decisions will be documented by treating clinicians based on the initial and subsequent imaging findings.
Sample Size and Statistical Analysis
This pilot study aims to recruit approximately 100 participants. Based on previous literature (Maconi et al., 2017), the study is powered to detect a difference in diagnostic sensitivity between TPUS and MRI. The analysis includes:
Calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) McNemar's test for paired comparisons Cohen's kappa for inter-modality agreement Receiver Operating Characteristic (ROC) curve analysis Subgroup analyses by diagnosis type and fistula location
Significance This is the first prospective study to compare all four major imaging modalities in the same patient cohort with suspected or confirmed perianal fistulas. By benchmarking TPUS and MRI against both EUS and EUA, the TRANSIT-CD study provides a robust framework for evaluating diagnostic accuracy and impact on care. The results may support broader use of TPUS as a first-line diagnostic tool, particularly in outpatient and low-resource settings where access to MRI or EUA is limited. It may also help refine imaging protocols for complex perianal Crohn's disease.
Ethical Considerations All imaging procedures in this study are part of routine clinical care. No experimental treatments are being tested. The study has been approved by the Institutional Ethics Committee and informed consent will be obtained from all participants. There are no additional risks introduced beyond standard diagnostic procedures. All data will be anonymized and securely stored.
- Being tested
- Transperineal Ultrasound (TPUS), Magnetic Resonance Imaging (MRI), Endoscopic Ultrasound (EUS), Examination Under Anesthesia (EUA)
- Keywords
- fistula, crohn disease, transperineal ultrasound, magnetic resonance imaging, endoscopic ultrasound, examination under anaesthesia
- Medical subject headings
- Crohn Disease, Fistula
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transperineal Ultrasound (TPUS)Diagnostic test
Participants will undergo TPUS using a high-frequency linear and microconvex probe to evaluate fistula tracts, internal openings, and abscesses.
Magnetic Resonance Imaging (MRI)Diagnostic test
MRI of the pelvis will be performed using standardized T2-weighted, STIR, and post-contrast sequences for anatomical characterization of fistulas.
Endoscopic Ultrasound (EUS)Diagnostic test
EUS of the anorectal canal will be performed using a linear echoendoscope to visualize internal openings, fistula tracts, and perirectal collections. EUS serves as the reference standard.
Examination Under Anesthesia (EUA)Diagnostic test
Participants will undergo EUA by a colorectal surgeon to probe fistula tracts and identify internal openings. EUA serves as the gold standard comparator.
| Study group | Role | What they receive |
|---|---|---|
| Single Group: Quadrimodal Imaging Assessment | Experimental | All participants in this arm will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each imaging modality will be used to evaluate the presence, type, and extent of perianal fistulas. This single-arm design allows within-subject comparison of diagnostic accuracy and clinical impact across modalities. Receives: Diagnostic Test: Transperineal Ultrasound (TPUS); Diagnostic Test: Magnetic Resonance Imaging (MRI); Diagnostic Test: Endoscopic Ultrasound (EUS); Diagnostic Test: Examination Under Anesthesia (EUA) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Per-lesion sensitivity of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) for detecting perianal fistulas
To determine and compare the diagnostic sensitivity of TPUS and MRI for identifying individual fistulous tracts, using endoscopic ultrasound (EUS) as the reference standard and examination under anesthesia (EUA) as the gold standard.
Measured: Within 10 days of enrollment (all four imaging modalities completed within this window)
Secondary outcomes (4)
Sensitivity of TPUS vs MRI for detecting internal openings
Compare how well TPUS and MRI detect internal openings of perianal fistulas, using EUS and EUA as benchmarks.
Measured: Within 10 days of enrollment
Classification accuracy (Parks criteria) of transperineal ultrasound (TPUS) versus magnetic resonance imaging (MRI)
Compare the ability of TPUS and MRI to correctly classify fistulas using the Parks classification system, compared to examination under anaesthesia (EUA).
Measured: Within 10 days of enrollment
Sensitivity of transperineal ultrasound (TPUS) vs magnetic resonance imaging (MRI) for detecting perianal abscesses
Evaluate the ability of TPUS and MRI to detect perianal abscesses compared with endoscopic ultrasound (EUS) and examinaion under anaesthesia (EUA).
Measured: Within 10 days of enrollment
Impact on clinical management based on imaging modality
Proportion of participants whose treatment plan was changed after magnetic resonance imaging (MRI) vs after transperineal ultrasound (TPUS).
Measured: Up to 14 days after imaging
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2026
- Study start25 Jul 2025
- Primary completion15 Apr 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Crohn Disease (CD)Studies of the same condition, open and under way.
- More trials run by Asian Institute of Gastroenterology, IndiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All participants will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each participant receives the same set of assessments, allowing within-subject comparisons across modalities. The goal is to evaluate the diagnostic accuracy and clinical impact of each imaging test for perianal fistulas in Crohn's disease and cryptogenic cases.
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Asian Institute of Gastroenterology, India
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07794410
- Sponsor's protocol ID
- AIG/IEC- BH&R 72/07.2025/03
- Acronym
- TRANSIT CD
- Status last verified
- Aug 2026
- First submitted
- 3 Aug 2025
- Last updated
- 31 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared publicly due to the nature of the diagnostic imaging data, which includes potentially identifiable health information. Data will be stored securely and used only by the study team for the purpose of predefined analyses. Any future data sharing will require additional ethical approval and participant consent.
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Quadrimodal Comparison of Transperineal Ultrasound and Magnetic Resonance Imaging-based Sonographic Investigation With Integrated Testing Using Endoscopic Ultrasound and Examination Under Anesthesia for the Assessment of Perianal Fistulas in Patients With Crohn's Disease and Fistulas of Cryptogenic Origin (TRANSIT-CD Study)
- ClinicalTrials.gov ID
- NCT07794410
- Acronym / sponsor ID
- TRANSIT CD / AIG/IEC- BH&R 72/07.2025/03
- Keywords
- fistula, crohn disease, transperineal ultrasound, magnetic resonance imaging, endoscopic ultrasound, examination under anaesthesia
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Asian Institute of Gastroenterology, IndiaUniversity, hospital or other
- Study start
- 25 Jul 2025 (actual)
- Primary completion
- 15 Apr 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 31 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with Crohn's disease or fistulas with no known cause (cryptogenic). Perianal fistulas are painful tunnels that form near the anus and can lead to discharge, swelling, or infection. The main questions this study aims to answer are:
How accurate is transperineal ultrasound (TPUS) compared to magnetic resonance imaging (MRI) in finding fistulas? How well do these tests identify key features like internal openings and abscesses? Do the test results help doctors make better treatment decisions?
Researchers will compare TPUS and MRI to two other imaging methods:
Endoscopic ultrasound (EUS), which uses a small camera and ultrasound inside the rectum Examination under anesthesia (EUA), in which a surgeon checks the area while the participant is asleep
All participants will:
Be adults between the ages of 18 and 75 Have a suspected or confirmed perianal fistula Be able to complete all four tests-TPUS, MRI, EUS, and EUA-within 10 days Participants will not receive any experimental treatments. The tests are part of routine care and will be done using advanced equipment by expert doctors. Each test result will be used to compare how accurate and useful the test is in real-life diagnosis and treatment planning.
This study may help make fistula diagnosis faster, safer, and more affordable-especially in settings where access to MRI or surgery is limited. It may also support the use of TPUS as a first step in evaluating perianal fistulas in people with Crohn's disease.
Detailed description
Perianal fistulas are a challenging and often debilitating complication of anorectal and inflammatory bowel diseases, particularly Crohn's disease. Up to 40% of people with Crohn's disease may develop perianal fistulas during the course of their illness. These fistulas are frequently complex, may recur, and can severely affect quality of life. They are associated with symptoms such as discharge, swelling, pain, infection, and, in some cases, incontinence or systemic sepsis. Accurate diagnosis and anatomical characterization of these fistulas are essential for determining the most effective medical and surgical treatment strategies.
Traditional imaging strategies include Magnetic Resonance Imaging (MRI), which is currently considered the non-invasive standard for anatomical delineation, and Examination Under Anesthesia (EUA), which serves as the gold standard due to the ability to directly examine the anatomy and intervene surgically if necessary. However, both methods have limitations. MRI is costly, may not be readily available in resource-limited settings, and is not suitable for all patients (e.g., those with certain implants or claustrophobia). EUA is invasive, requires anesthesia, and may not be feasible for repeated use in follow-up or outpatient care.
Alternative imaging modalities such as Transperineal Ultrasound (TPUS) and Endoscopic Ultrasound (EUS) are being explored for their diagnostic utility. TPUS is a non-invasive, low-cost, real-time modality that can be performed at the bedside or in outpatient settings. EUS, while more invasive, offers high-resolution images of the anal canal and surrounding structures and is increasingly used for evaluating anorectal diseases.
The TRANSIT-CD study (A Quadrimodal Comparison of TRAnsperiNeal and MR-based Sonographic Investigation with Integrated Testing using Endoscopic Ultrasound and Examination Under Anesthesia) is a prospective, single-center, diagnostic accuracy study designed to compare the performance of four imaging modalities-TPUS, MRI, EUS, and EUA-in evaluating perianal fistulas in people with Crohn's disease and cryptogenic (non-Crohn's) fistulas.
Study Design and Objectives The study will enroll adults aged 18 to 75 years with a clinical diagnosis or suspicion of perianal fistula. Each participant will undergo four imaging tests-TPUS, MRI, EUS, and EUA-within a maximum interval of 10 days. The order of testing is predefined and all interpretations will be performed independently by blinded experts in each modality.
The primary objective is to compare the per-lesion sensitivity of TPUS and MRI for detecting perianal fistulas, using EUS as the reference standard and EUA as the gold standard.
Secondary objectives include:
Comparing TPUS and MRI for detecting internal openings and perianal abscesses Evaluating classification accuracy using Parks classification and American Gastroenterological Association (AGA) criteria (simple vs. complex fistulas) Determining whether findings from TPUS and MRI result in a change in clinical management
Exploratory objectives include:
Assessing diagnostic accuracy by disease type (Crohn's vs. cryptogenic) Comparing modality performance in high (above the levator ani muscle) vs. low fistulas Evaluating inter-modality agreement and confidence levels of reporting physicians Methodology
Transperineal Ultrasound (TPUS) Performed by an expert radiologist using a high-end ultrasound platform with microconvex and high-frequency linear probes. The patient is positioned in the left lateral decubitus position. Both axial and sagittal images are obtained. Parameters assessed include tract presence, type, internal openings, secondary extensions, and associated abscesses.
Magnetic Resonance Imaging (MRI) Conducted using a 1.5 Tesla MRI scanner with T2-weighted, STIR, and post-contrast T1-weighted fat-suppressed sequences in axial, sagittal, and coronal planes. MRI findings are independently interpreted by radiologists blinded to TPUS and EUS findings. Fistulas are characterized using standard classification systems and the presence of abscesses and internal openings is documented.
Endoscopic Ultrasound (EUS) EUS is performed using a linear echoendoscope and dedicated EUS processor. The procedure does not require bowel preparation. A 360-degree evaluation of the anal canal and surrounding structures is performed to detect fistulous tracts, internal openings, and collections. EUS serves as the reference standard for diagnostic comparison.
Examination Under Anesthesia (EUA) EUA is performed by an experienced colorectal surgeon under spinal or general anesthesia. This procedure allows direct probing of the fistula tract, identification of internal openings, and classification of the fistula using tactile and visual assessment. EUA is considered the gold standard in this study.
Each modality's findings are documented in structured case report forms. The findings include:
Fistula presence and number Parks classification and AGA complexity score Internal and external openings Abscess presence and dimensions Secondary tracts Confidence scores All data are recorded per lesion, per patient.
Blinding and Data Integrity All imaging studies will be interpreted independently by modality-specific experts, who are blinded to the findings of other modalities. Discrepant findings will be resolved through consensus by the principal investigators. A secure electronic database will be used for data capture, ensuring patient confidentiality and auditability.
Clinical Impact Assessment The study will also track whether imaging findings lead to a change in management plans (e.g., additional imaging, medical therapy, surgical planning). These decisions will be documented by treating clinicians based on the initial and subsequent imaging findings.
Sample Size and Statistical Analysis
This pilot study aims to recruit approximately 100 participants. Based on previous literature (Maconi et al., 2017), the study is powered to detect a difference in diagnostic sensitivity between TPUS and MRI. The analysis includes:
Calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) McNemar's test for paired comparisons Cohen's kappa for inter-modality agreement Receiver Operating Characteristic (ROC) curve analysis Subgroup analyses by diagnosis type and fistula location
Significance This is the first prospective study to compare all four major imaging modalities in the same patient cohort with suspected or confirmed perianal fistulas. By benchmarking TPUS and MRI against both EUS and EUA, the TRANSIT-CD study provides a robust framework for evaluating diagnostic accuracy and impact on care. The results may support broader use of TPUS as a first-line diagnostic tool, particularly in outpatient and low-resource settings where access to MRI or EUA is limited. It may also help refine imaging protocols for complex perianal Crohn's disease.
Ethical Considerations All imaging procedures in this study are part of routine clinical care. No experimental treatments are being tested. The study has been approved by the Institutional Ethics Committee and informed consent will be obtained from all participants. There are no additional risks introduced beyond standard diagnostic procedures. All data will be anonymized and securely stored.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All participants will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each participant receives the same set of assessments, allowing within-subject comparisons across modalities. The goal is to evaluate the diagnostic accuracy and clinical impact of each imaging test for perianal fistulas in Crohn's disease and cryptogenic cases.
| Arm | Type | Receives |
|---|---|---|
| Single Group: Quadrimodal Imaging Assessment | Experimental | Diagnostic Test: Transperineal Ultrasound (TPUS), Diagnostic Test: Magnetic Resonance Imaging (MRI), Diagnostic Test: Endoscopic Ultrasound (EUS), Diagnostic Test: Examination Under Anesthesia (EUA)All participants in this arm will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each imaging modality will be used to evaluate the presence, type, and extent of perianal fistulas. This single-arm design allows within-subject comparison of diagnostic accuracy and clinical impact across modalities. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adults between 18 and 75 years of age
- Clinical suspicion or diagnosis of perianal fistula
- Fistula etiology can be Crohn's disease or cryptogenic/tubercular (non-Crohn's)
- Ability to undergo all four imaging procedures (TPUS, MRI, EUS, and EUA) within a 10-day period
- Willing and able to provide written informed consent
Key exclusion criteria (9 listed)
- Known or suspected anorectal malignancy
- Pregnancy or breastfeeding
- Contraindications to any of the imaging procedures:
- MRI (e.g., presence of metal implants or claustrophobia)
- EUS (e.g., severe anal stenosis or intolerance to procedure)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transperineal Ultrasound (TPUS)Participants will undergo TPUS using a high-frequency linear and microconvex probe to evaluate fistula tracts, internal openings, and abscesses. | Diagnostic test | Single Group: Quadrimodal Imaging Assessment |
| Magnetic Resonance Imaging (MRI)MRI of the pelvis will be performed using standardized T2-weighted, STIR, and post-contrast sequences for anatomical characterization of fistulas. | Diagnostic test | Single Group: Quadrimodal Imaging Assessment |
| Endoscopic Ultrasound (EUS)EUS of the anorectal canal will be performed using a linear echoendoscope to visualize internal openings, fistula tracts, and perirectal collections. EUS serves as the reference standard. | Diagnostic test | Single Group: Quadrimodal Imaging Assessment |
| Examination Under Anesthesia (EUA)Participants will undergo EUA by a colorectal surgeon to probe fistula tracts and identify internal openings. EUA serves as the gold standard comparator. | Diagnostic test | Single Group: Quadrimodal Imaging Assessment |
Primary outcome
Per-lesion sensitivity of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) for detecting perianal fistulas
Time frame: Within 10 days of enrollment (all four imaging modalities completed within this window)
To determine and compare the diagnostic sensitivity of TPUS and MRI for identifying individual fistulous tracts, using endoscopic ultrasound (EUS) as the reference standard and examination under anesthesia (EUA) as the gold standard.
4 secondary outcomes
Sensitivity of TPUS vs MRI for detecting internal openings
Time frame: Within 10 days of enrollment
Classification accuracy (Parks criteria) of transperineal ultrasound (TPUS) versus magnetic resonance imaging (MRI)
Time frame: Within 10 days of enrollment
Sensitivity of transperineal ultrasound (TPUS) vs magnetic resonance imaging (MRI) for detecting perianal abscesses
Time frame: Within 10 days of enrollment
Impact on clinical management based on imaging modality
Time frame: Up to 14 days after imaging
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared publicly due to the nature of the diagnostic imaging data, which includes potentially identifiable health information. Data will be stored securely and used only by the study team for the purpose of predefined analyses. Any future data sharing will require additional ethical approval and participant consent.
Related trials for Crohn Disease (CD)
RecruitingObservational study
Ibd CAncer and seRious Infections in France (I-CARE 2)
IBD, Ulcerative Colitis
RecruitingObservational study
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
Crohn Disease (CD), Colitis Ulcerative
RecruitingPhase 4
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Crohn Disease (CD)
RecruitingPhase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Inflammatory Bowel Diseases, Crohn's Disease
RecruitingPhase 4
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Crohn Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transperineal Ultrasound (TPUS), Magnetic Resonance Imaging (MRI) and Endoscopic Ultrasound (EUS) in people with Crohn Disease (CD) and Cryptoglandular Perianal Fistula, run by Asian Institute of Gastroenterology, India at 1 site in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Partha Pal, MD, DNB, MRCP (UK), FASGE (+918945906823, partha0123456789@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Per-lesion sensitivity of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) for detecting perianal fistulas (time frame: Within 10 days of enrollment (all four imaging modalities completed within this window)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.